Insider · CIK 0001188757

FARRELL STEPHEN C

Reports to the SEC for 5 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001188757

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-03-05	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−10K sh	—	—	0
2025-03-05	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−10K sh	—	—	0
2025-03-05	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+10K sh	$5.54	+$55.4K	25,156
2025-03-05	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+10K sh	$8.35	+$83.5K	35,156
2025-02-26	STAASTAAR SURGICAL CO · Restricted Stock UnitsA Award	Director, President & CEO	AAward	+200K sh	—	—	200,000
2024-06-20	STAASTAAR SURGICAL COA Award	Director, President & CEO	AAward	+2,244 sh	—	—	15,156
2024-06-20	STAASTAAR SURGICAL CO · Common Stock OptionsA Award	Director, President & CEO	AAward	+4,010 sh	—	—	4,010
2023-12-29	STAASTAAR SURGICAL COA Award	Director, President & CEO	AAward	+921 sh	$31.21	+$28.7K	12,912
2023-11-06	STAASTAAR SURGICAL COA Award	Director, President & CEO	AAward	+3,000 sh	$35.15	+$105K	11,991
2023-09-29	STAASTAAR SURGICAL COA Award	Director, President & CEO	AAward	+715 sh	$40.18	+$28.7K	8,991
2023-06-15	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+1,709 sh	—	—	8,276
2023-06-15	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+3,127 sh	—	—	3,127
2022-10-07	Convey Health Solutions Holdings, Inc.D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−163K sh	$10.50	−$1.72M	4,734
2022-10-07	Convey Health Solutions Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−356K sh	—	—	0
2022-10-07	Convey Health Solutions Holdings, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−525K sh	—	—	0
2022-10-07	Convey Health Solutions Holdings, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−976K sh	—	—	0
2022-06-16	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+355 sh	—	—	6,567
2022-06-16	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+5,765 sh	—	—	5,765
2022-03-28	Convey Health Solutions Holdings, Inc.Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+356K sh	—	—	355,561
2021-06-24	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+850 sh	—	—	850
2021-06-24	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+404 sh	—	—	6,212
2021-06-18	Convey Health Solutions Holdings, Inc.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+45K sh	$13.00	+$585K	636,862
2021-05-28	STAASTAAR SURGICAL COD Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−5,000 sh	$150.00	−$750K	5,808
2021-05-28	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+5,000 sh	$5.54	+$27.7K	10,808
2021-05-28	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−5,000 sh	—	—	10,000
2021-05-26	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−5,000 sh	—	—	0
2021-05-26	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+5,000 sh	$7.14	+$35.7K	10,808
2021-05-26	STAASTAAR SURGICAL COD Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−5,000 sh	$135.00	−$675K	5,808
2021-05-19	STAASTAAR SURGICAL COD Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−5,000 sh	$120.00	−$600K	5,808
2021-05-19	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+5,000 sh	$5.54	+$27.7K	10,808
2021-05-19	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−5,000 sh	—	—	15,000
2021-05-17	STAASTAAR SURGICAL COD Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−5,328 sh	$113.87	−$607K	5,808
2021-05-17	STAASTAAR SURGICAL COM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+5,328 sh	$7.14	+$38K	11,136
2021-05-17	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−5,328 sh	—	—	5,000
2020-07-30	STAASTAAR SURGICAL COA Award	Director, President & CEO	AAward	+2,117 sh	—	—	5,808
2020-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2019-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2019-06-20	STAASTAAR SURGICAL CO · Common Stock OptionsA Award	Director, President & CEO	AAward	+8,536 sh	—	—	8,536
2018-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+40K sh	—	—	40,000
2018-06-14	STAASTAAR SURGICAL COA Award	Director, President & CEO	AAward	+3,691 sh	—	—	3,691
2018-03-15	STAASTAAR SURGICAL CO · Common Stock OptionsA Award	Director, President & CEO	AAward	+1,206 sh	—	—	1,206
2017-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+20K sh	—	—	20,000
2017-06-13	STAASTAAR SURGICAL CO · Common Stock OptionsA Award	Director, President & CEO	AAward	+19.8K sh	—	—	19,841
2016-08-08	STAASTAAR SURGICAL CO · Common Stock OptionsA Award	Director, President & CEO	AAward	+10K sh	—	—	10,000
2016-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+20K sh	—	—	20,000
2016-06-24	STAASTAAR SURGICAL CO · Common Stock OptionsA Award	Director, President & CEO	AAward	+20K sh	—	—	20,000
2016-01-01	STAASTAAR SURGICAL CO · Common Stock OptionsA Award	Director, President & CEO	AAward	+10.3K sh	—	—	10,328
2015-11-06	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director	PPurchase	+50K sh	$3.83	+$192K	97,450
2015-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+20K sh	—	—	20,000
2014-10-08	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director	PPurchase	+32.1K sh	$3.12	+$100K	47,450

Recent filings

Accepted (ET)
Mar 64
FARRELL STEPHEN C0000950170-25-034960
SEC(opens sec.gov)
Feb 284
FARRELL STEPHEN C0000950170-25-029986
SEC(opens sec.gov)
Jun 244
FARRELL STEPHEN C0000950170-24-076869
SEC(opens sec.gov)
Jan 24
FARRELL STEPHEN C0001209191-24-000221
SEC(opens sec.gov)
Nov 64
FARRELL STEPHEN C0001209191-23-054514
SEC(opens sec.gov)
Oct 34
FARRELL STEPHEN C0001209191-23-051748
SEC(opens sec.gov)
Jun 164
FARRELL STEPHEN C0001209191-23-038172
SEC(opens sec.gov)
Oct 124
FARRELL STEPHEN C0000950103-22-017700
SEC(opens sec.gov)
Jun 174
FARRELL STEPHEN C0001209191-22-038092
SEC(opens sec.gov)
Mar 304
FARRELL STEPHEN C0001104659-22-040170
SEC(opens sec.gov)
Jun 254
FARRELL STEPHEN C0001209191-21-043359
SEC(opens sec.gov)

Companies

Address

52 ADAMS STREET

LEXINGTON, MA, 02420